Press Release: Robert (Bob) Radie and Ulrik Schulze Join the Biograil Board of Directors
COPENHAGEN, DENMARK, Dec 17th, 2025 – Biograil ApS, a Copenhagen based biotech company developing a unique oral device for delivery of therapeutics […]
Author: Karsten Lindhardt
Press Release: Biograil raises EUR 8.5 million to support clinical testing of oral therapeutic delivery device
COPENHAGEN, DENMARK, July 1st, 2025 – Biograil ApS, a Copenhagen based biotech company developing a unique oral device for delivery of therapeutics […]
Press Release: Biograil and CSL Sign Collaboration Agreement for development of certain CSL compounds using Biograil’s proprietary BIONDD™ technology.
COPENHAGEN, DENMARK, July 17th, 2024 – Biograil ApS, a Copenhagen based biotech company developing a unique oral device for delivery of therapeutics […]
Press Release: Biograil and Lilly Sign Collaboration and License Agreement
COPENHAGEN, DENMARK, October 4th, 2022 – Biograil ApS, a Copenhagen based biotech company developing a unique oral device for delivery of therapeutics […]
Press Release: Biograil Receives Innobooster Grant Providing Non-dilutive funding for BIONDD™ in Preparations for Phase 1 clinical trials
COPENHAGEN, DENMARK, 14 March, 2022 – Biograil ApS, a Copenhagen based biotech company developing a unique oral device for delivery of biologics […]
Press Release: Biograil Forms International Scientific Advisory Board
COPENHAGEN, DENMARK, March 1st, 2022 – Biograil ApS, a Copenhagen based biotech company developing a unique oral device for delivery of biologics […]
Press Release: Biograil Secures Seed 2 Funding for Oral Delivery Device for Biologics
COPENHAGEN, DENMARK, Feb 17th, 2022 – Biograil ApS, a Copenhagen based biotech company developing a unique oral device for delivery of biologics […]